Katherine E. Di Palo

1.1k total citations
23 papers, 634 citations indexed

About

Katherine E. Di Palo is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice and Geriatrics and Gerontology. According to data from OpenAlex, Katherine E. Di Palo has authored 23 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 7 papers in Family Practice and 6 papers in Geriatrics and Gerontology. Recurrent topics in Katherine E. Di Palo's work include Heart Failure Treatment and Management (12 papers), Medication Adherence and Compliance (7 papers) and Cardiac Health and Mental Health (7 papers). Katherine E. Di Palo is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Medication Adherence and Compliance (7 papers) and Cardiac Health and Mental Health (7 papers). Katherine E. Di Palo collaborates with scholars based in United States, Australia and Norway. Katherine E. Di Palo's co-authors include Ileana L. Piña, Héctor O. Ventura, Evann Eisenberg, Michael Goldfarb, Petter Andreas Ringen, Marc D. Binder, Johan Detraux, Jamie A. Cvengros, Laurie P. Whitsel and Niteesh K. Choudhry and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Katherine E. Di Palo

21 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E. Di Palo United States 12 344 67 65 59 58 23 634
Carolyn H. Still United States 15 311 0.9× 138 2.1× 44 0.7× 65 1.1× 42 0.7× 42 637
Mary Ann Bauman United States 5 380 1.1× 51 0.8× 95 1.5× 58 1.0× 23 0.4× 7 650
Rogério Baumgratz de Paula Brazil 17 272 0.8× 72 1.1× 29 0.4× 90 1.5× 78 1.3× 63 983
Bianca Kollhorst Germany 14 186 0.5× 37 0.6× 119 1.8× 55 0.9× 40 0.7× 51 721
Margaret Kiser United States 12 325 0.9× 44 0.7× 67 1.0× 77 1.3× 37 0.6× 15 899
Jocelyn S. Thompson United States 15 377 1.1× 151 2.3× 35 0.5× 29 0.5× 29 0.5× 40 898
Yu-Wen Wen Taiwan 15 188 0.5× 44 0.7× 57 0.9× 52 0.9× 35 0.6× 24 659
Laure Rouch France 11 241 0.7× 40 0.6× 144 2.2× 40 0.7× 29 0.5× 34 562
Brittany Butts United States 14 214 0.6× 33 0.5× 31 0.5× 86 1.5× 140 2.4× 33 516
Sipke T. Visser Netherlands 15 155 0.5× 18 0.3× 87 1.3× 62 1.1× 31 0.5× 28 641

Countries citing papers authored by Katherine E. Di Palo

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Di Palo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Di Palo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Di Palo more than expected).

Fields of papers citing papers by Katherine E. Di Palo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Di Palo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Di Palo. The network helps show where Katherine E. Di Palo may publish in the future.

Co-authorship network of co-authors of Katherine E. Di Palo

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Di Palo. A scholar is included among the top collaborators of Katherine E. Di Palo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Di Palo. Katherine E. Di Palo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Filtz, Annalisa, Niranjan Kathe, Eduard Sidelnikov, et al.. (2025). Disparities in achieving low-density lipoprotein cholesterol goals after revascularization in a diverse real-world cohort. European Journal of Preventive Cardiology. 32(13). 1192–1201. 1 indexed citations
3.
Goldfarb, Michael, Martha Abshire Saylor, Biykem Bozkurt, et al.. (2024). Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association. Circulation. 149(20). e1176–e1188. 22 indexed citations
4.
Palo, Katherine E. Di, Shelli L. Feder, Daniel E. Forman, et al.. (2024). Palliative Pharmacotherapy for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation Cardiovascular Quality and Outcomes. 17(8). e000131–e000131. 7 indexed citations
5.
Golestaneh, Ladan, et al.. (2024). A Retrospective Study of Patiromer as Adjunct to Insulin Therapy for Acute Hyperkalemia in the Emergency Department. Open Access Emergency Medicine. Volume 16. 305–312. 1 indexed citations
6.
Bauman, Laurie J., et al.. (2024). Multidisciplinary proactive e-consults to improve guideline-directed medical therapies for patients with diabetes and chronic kidney disease: an implementation study. BMJ Open Diabetes Research & Care. 12(3). e004155–e004155. 4 indexed citations
7.
Goldfarb, Michael, Marc D. Binder, Johan Detraux, et al.. (2022). Severe Mental Illness and Cardiovascular Disease. Journal of the American College of Cardiology. 80(9). 918–933. 88 indexed citations
8.
Palo, Katherine E. Di. (2022). Psychological Disorders in Heart Failure. Cardiology Clinics. 40(2). 269–276. 7 indexed citations
9.
Palo, Katherine E. Di, et al.. (2022). Assessment of Patiromer Monotherapy for Hyperkalemia in an Acute Care Setting. JAMA Network Open. 5(1). e2145236–e2145236. 15 indexed citations
10.
Palo, Katherine E. Di, et al.. (2022). Hypertension and Heart Failure. Cardiology Clinics. 40(2). 237–244. 38 indexed citations
11.
Piña, Ileana L., Katherine E. Di Palo, Marie T. Brown, et al.. (2020). Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association. Progress in Cardiovascular Diseases. 64. 111–120. 43 indexed citations
12.
Palo, Katherine E. Di. (2020). Hypertension and heart failure: focus on high-risk populations. Current Opinion in Cardiology. 35(4). 381–388. 2 indexed citations
13.
Palo, Katherine E. Di, et al.. (2019). Hypertension and Heart Failure. Heart Failure Clinics. 16(1). 99–106. 115 indexed citations
14.
Palo, Katherine E. Di. (2019). Psychological Disorders in Heart Failure. Heart Failure Clinics. 16(1). 131–138. 15 indexed citations
15.
Palo, Katherine E. Di, et al.. (2018). The role of the pharmacist in hypertension management. Current Opinion in Cardiology. 33(4). 382–387. 26 indexed citations
16.
Piña, Ileana L., Katherine E. Di Palo, & Héctor O. Ventura. (2018). Psychopharmacology and Cardiovascular Disease. Journal of the American College of Cardiology. 71(20). 2346–2359. 88 indexed citations
17.
Palo, Katherine E. Di, Ileana L. Piña, & Héctor O. Ventura. (2018). Improving Provider Adherence to Guideline Recommendations in Heart Failure. Current Heart Failure Reports. 15(6). 350–356. 4 indexed citations
18.
Palo, Katherine E. Di, et al.. (2018). Risk Reduction to Disease Management: Clinical Pharmacists as Cardiovascular Care Providers. Current Problems in Cardiology. 44(9). 276–293. 3 indexed citations
19.
Palo, Katherine E. Di, et al.. (2017). Implementation of a Patient Navigator Program to Reduce 30-day Heart Failure Readmission Rate. Progress in Cardiovascular Diseases. 60(2). 259–266. 46 indexed citations
20.
Boockvar, Kenneth S., William Ho, Jennifer Pruskowski, et al.. (2017). Effect of health information exchange on recognition of medication discrepancies is interrupted when data charges are introduced: results of a cluster-randomized controlled trial. Journal of the American Medical Informatics Association. 24(6). 1095–1101. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026